Latest Post
Navigating Insurance Audits as a PMHNP: Protect Your Practice and Your License
Insurance audits are increasing for psychiatric providers in 2026, targeting documentation quality, medical necessity, and E/M code accuracy.
The Fellowship Blog
Clinical Insights & Resources
Real talk about psychopharmacology, clinical confidence, and building a practice you love — from Lindsay and the Fellowship faculty.
All Posts Career & Business Career & Certification Clinical Practice Industry PMHNP Confidence Private Practice
More Articles
Clinical Practice
Ketamine and Esketamine in Psychiatric Practice: What PMHNPs Need to Know in 2026
Ketamine and esketamine are reshaping treatment-resistant depression care, with expanded indications and new delivery models emerging in 2026.
PMHNP Confidence
How to Find a PMHNP Mentor — A Practical Guide
If you’ve typed “how to find a PMHNP mentor” into a search bar, you already know the answer isn’t simple. Unlike medical residencies where mentorship is...
Clinical Practice
Buprenorphine Prescribing for PMHNPs: What Changed After the X-Waiver Elimination
With the X-waiver eliminated, all DEA-licensed PMHNPs can now prescribe buprenorphine for opioid use disorder without special certification.
PMHNP Confidence
PMHNP Imposter Syndrome — Why You Feel Like a Fraud (And What to Do About It)
Imposter syndrome affects up to 70% of new PMHNPs, creating self-doubt that can stall clinical growth and lead to burnout.
Career & Business
Starting a Psychiatric Private Practice in 2026: The Complete PMHNP Roadmap
Launching a psychiatric private practice as a PMHNP in 2026 requires navigating credentialing, insurance paneling, EHR selection, and business formation.
Clinical Practice
Lithium Prescribing in 2026: Updated Renal Safety Guidelines for PMHNPs
New 2026 consensus guidelines revise lithium renal monitoring protocols, recommending eGFR checks every 3 months for the first year and introducing...
Clinical Practice
Clozapine Monitoring Updates 2026: REMS Changes Every PMHNP Must Know
The FDA has streamlined clozapine REMS requirements for 2026, reducing ANC monitoring frequency for established patients while maintaining safety...
PMHNP Confidence
PMHNP Mentorship That Makes a Difference
You earned your degree. You passed your boards. And then you sat down across from your first real patient — the one whose chart didn’t match any textbook...
Career & Business
DEA Telehealth Prescribing Rules for 2026: What PMHNPs Running a Practice Need to Know
The DEA extended telehealth prescribing flexibilities for controlled substances through December 2026. Here's what PMHNPs building telehealth practices need to know before permanent rules arrive.